5项改良衰弱指数用于乳房重建组织扩张器置入术前风险评估
基于2012至2018年美国外科医师学会国家手术质量改进项目数据库,纳入44728例组织扩张器置入病例,评估5项改良衰弱指数(mFI-5)对术后并发症的预测效能。结果显示总体并发症率为10.5%(n=4674),mFI-5在校正年龄、BMI、ASA分级和吸烟史后仍是效应量最大的并发症预测因子。
要点
- mFI-5可有效预测组织扩张器置入术后并发症
- 校正混杂因素后mFI-5效应量仍最大(OR 2.25)
- mFI-5对手术裂开、手术部位感染、再手术和再入院的预测优于其各单项成分
核心结论
- mFI-5可作为组织扩张器置入患者术后并发症的有效术前预测工具,其效应量大于其他传统围手术期危险因素,且优于其各单项成分。
研究设计与样本
- 回顾性队列研究,使用2012至2018年美国外科医师学会国家手术质量改进项目(ACS NSQIP)数据库,纳入44728例组织扩张器置入病例,采用单因素和多因素回归分析。
主要发现
- 总体并发症率为10.5%(n=4674),发生并发症组mFI-5评分显著更高(0.08 vs 0.06,P<0.001)。
临床怎么用
- 乳房重建组织扩张器置入术前可用mFI-5辅助风险分层,识别高危患者以优化围手术期管理。
局限性
- 原文摘要未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preoperative risk assessment is essential in determining which surgical candidates will have the most to gain from an operation. The 5-item modified frailty index (mFI-5) has been validated as an effective way to determine this risk. This study sought to evaluate the performance of the mFI-5 as a predictor of postoperative complications after tissue expander placement. METHODS: Patients who underwent placement of a tissue expander were identified using the 2012 to 2018 American College of Surgeons National Surgical Quality Improvement Project database. Univariate and multivariate regression analysis models were used to assess how mFI-5, the components of the mFI-5 (functional status, diabetes, chronic obstructive pulmonary disease, chronic heart failure, and hypertension), and other factors commonly used to risk stratify (age, body mass index [BMI], American Society of Anesthesiologists (ASA) classification, and history of smoking) were associated with complications. RESULTS: In 44,728 tissue expander placement cases, the overall complication rate was 10.5% (n = 4674). The mFI-5 score was significantly higher in the group that experienced complications (0.08 vs 0.06, P < 0.001). Compared with the mFI-5 individual components and other common variables used preoperatively to risk stratify patients, univariate analysis demonstrated that mFI-5 had the largest effect size (odds ratio [OR], 5.46; confidence interval [CI], 4.29-6.94; P < 0.001). After controlling for age, BMI, ASA classification, and history of smoking, the mFI-5 still remained the predictor of complications with the largest effect size (OR, 2.25; CI, 1.70-2.97; P < 0.001). In assessing specific complications, the mFI-5 is the independent predictor with the largest significant effect size for surgical dehiscence (OR, 12.76; CI, 5.58-28.18; P < 0.001), surgical site infection (OR, 6.68; CI, 4.53-9.78; P < 0.001), reoperation (OR, 5.23; CI, 3.90-6.99; P < 0.001), and readmission (OR, 4.59; CI, 3.25-6.45; P < 0.001) when compared with age, BMI, ASA class, and/or history of smoking alone. CONCLUSIONS: The mFI-5 can be used as an effective preoperative predictor of postoperative complications in patients undergoing tissue expander placement. Not only does it have the largest effect size compared with other historical perioperative risk factors, it is more predictive than each of its individual components.
引用
- Moss W, Zhang R, Carter GC, et al. A Case for the Use of the 5-Item Modified Frailty Index in Preoperative Risk Assessment for Tissue Expander Placement in Breast Reconstruction. Ann Plast Surg. 2022. PMID: 33625029. doi:10.1097/SAP.0000000000002771
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。